Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3172)
All Articles published online
|
Sep 15, 2004 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu YL, Ye J, Zhang S, Zhong J, Xi RP. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World J Gastroenterol 2004; 10(18): 2740-2743 [PMID: 15309731 DOI: 10.3748/wjg.v10.i18.2740] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i18/2740.htm |
| Number | Citing Articles |
| 1 |
Peter Holland-Fischer, Hendrik Vilstrup, Jan Frystyk, Dennis Tønner Nielsen, Allan Flyvbjerg, Henning Grønbæk. The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. European Journal of Endocrinology 2009; 160(6): 957 doi: 10.1530/EJE-08-0971
|
| 2 |
Fernando Bril, Alicia Elbert. Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?. Metabolism 2025; 162: 156066 doi: 10.1016/j.metabol.2024.156066
|
| 3 |
Jeroen Kool, Léon Reubsaet, Feikje Wesseldijk, Raquel T. Maravilha, Martijn W. Pinkse, Clive S. D'Santos, Jacobus J. van Hilten, Freek J. Zijlstra, Albert J. R. Heck. Suction blister fluid as potential body fluid for biomarker proteins. PROTEOMICS 2007; 7(20): 3638 doi: 10.1002/pmic.200600938
|
| 4 |
Bruno da Silveira Colombo, Marcelo Fernando Ronsoni, Pedro Eduardo Soares e Silva, Leonardo Fayad, Letícia Muraro Wildner, Maria Luiza Bazzo, Esther Buzaglo Dantas-Correa, Janaína Luz Narciso-Schiavon, Leonardo Lucca Schiavon. Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis. Biomarkers 2017; 22(2): 127 doi: 10.1080/1354750X.2016.1252949
|
| 5 |
Archana Hari, Mohamed Diwan M. AbdulHameed, Michele R. Balik-Meisner, Deepak Mav, Dhiral P. Phadke, Elizabeth H. Scholl, Ruchir R. Shah, Warren Casey, Scott S. Auerbach, Anders Wallqvist, Venkat R. Pannala. Exposure to PFAS chemicals induces sex-dependent alterations in key rate-limiting steps of lipid metabolism in liver steatosis. Frontiers in Toxicology 2024; 6 doi: 10.3389/ftox.2024.1390196
|
| 6 |
N. Li, L. Zhou, B. Zhang, P. Dong, W. Lin, H. Wang, R. Xu, H. Ding. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: A pilot open, randomized, and controlled clinical trial. Digestive and Liver Disease 2008; 40(7): 554 doi: 10.1016/j.dld.2007.11.011
|
| 7 |
Marcelo Fernando Ronsoni, Cesar Lazzarotto, Leonardo Fayad, Mariana Costa Silva, Christiane Lourenço Nogueira, Maria Luiza Bazzo, Janaína Luz Narciso-Schiavon, Esther Buzaglo Dantas-Corrêa, Leonardo de Lucca Schiavon. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis. Annals of Hepatology 2013; 12(3): 456 doi: 10.1016/S1665-2681(19)31009-9
|
| 8 |
S. Neumann, H. Welling, S. Thuere. Insulin‐like Growth Factor I Concentration in Dogs with Inflammatory and Neoplastic Liver Diseases. Journal of Veterinary Medicine Series A 2007; 54(10): 612 doi: 10.1111/j.1439-0442.2007.00982.x
|
| 9 |
Ulrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, Kira Simonsen, Poul Frølund Vestergaard, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Hendrik Vilstrup, Jan Frystyk. The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment. Growth Hormone & IGF Research 2015; 25(4): 174 doi: 10.1016/j.ghir.2015.05.002
|
| 10 |
Ilkay Aksu, Basak Baykara, Muge Kiray, Tugba Gurpinar, Ali Riza Sisman, Nuran Ekerbicer, Aysegul Tas, Ozden Gokdemir-Yazar, Nazan Uysal. Serum IGF-1 levels correlate negatively to liver damage in diabetic rats. Biotechnic & Histochemistry 2013; 88(3-4): 194 doi: 10.3109/10520295.2012.758311
|
| 11 |
Asghar Khoshnood, Mohsen Nasiri Toosi, Mohammad Jafar Faravash, Alireza Esteghamati, Hosein Froutan, Hadi Ghofrani, Mohammad Kalani, Arash Miroliaee, Ahmad Abdollahi, Andrabi Yasir. A Survey of Correlation Between Insulin-Like Growth Factor-I (IGF-I) Levels and Severity of Liver Cirrhosis. Hepatitis Monthly 2013; 13(2) doi: 10.5812/hepatmon.6181
|
| 12 |
Lilith M. Caballero Aguilar, Saimon M. Silva, Simon E. Moulton. Growth factor delivery: Defining the next generation platforms for tissue engineering. Journal of Controlled Release 2019; 306: 40 doi: 10.1016/j.jconrel.2019.05.028
|
| 13 |
Mona A. Abu El-Makarem, Mariana F. Kamel, Ahmed A. Mohamed, Hisham A. Ali, Mahmoud R. Mohamed, Alaa El-Deen M. Mohamed, Ahmed M. El-Said, Mahmoud G. Ameen, Alshymaa A. Hassnine, Hatem A. Hassan, Gianfranco D. Alpini. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor. PLOS ONE 2022; 17(11): e0277266 doi: 10.1371/journal.pone.0277266
|
| 14 |
Dong Hyeon Lee, Jeong-Hoon Lee, Yong Jin Jung, Jungsoo Gim, Won Kim, Byeong Gwan Kim, Kook Lae Lee, Yuri Cho, Jeong-Ju Yoo, Minjong Lee, Young Youn Cho, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu. Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area. PLOS ONE 2017; 12(1): e0170394 doi: 10.1371/journal.pone.0170394
|
| 15 |
G. Serrano, N. Devriendt, D. Paepe, H. de Rooster. Serum insulin-like growth factor-1 as a marker of improved liver function and surgical outcome in dogs with congenital extrahepatic portosystemic shunts. The Veterinary Journal 2021; 274: 105716 doi: 10.1016/j.tvjl.2021.105716
|
| 16 |
Daphné Rochel, Myriam Burger, Patrick Nguyen, Laetitia Jaillardon. Insulin-like growth factor type 1 concentrations in hyperthyroid cats before and after treatment with thiamazole. Journal of Feline Medicine and Surgery 2018; 20(2): 179 doi: 10.1177/1098612X17694735
|
| 17 |
Seyed Mohsen Dehghani, Hamdollah Karamifar, Seyedeh Sedigheh Hamzavi, Mahmood Haghighat, Seyed Ali Malek-Hosseini. Serum Insulinlike Growth Factor-1 and Its Binding Protein-3 Levels in Children With Cirrhosis Waiting for a Liver Transplant. Experimental and Clinical Transplantation 2012; 10(3): 252 doi: 10.6002/ect.2011.0095
|
| 18 |
Ilona Argirion, Ruth M. Pfeiffer, Tram Kim Lam, Thomas R. O’Brien, Kelly Yu, Katherine A. McGlynn, Jessica L. Petrick, Ligia Pinto, Chien-Jen Chen, Mei-Hsuan Lee, Allan Hildesheim, Hwai-I Yang, Jill Koshiol. Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00455-8
|
| 19 |
EIMAN ALEEM, AYMAN ELSHAYEB, NIHAL ELHABACHI, AMAL REFAAT MANSOUR, AHMED GOWILY, ASMAA HELA. Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncology Letters 2012; 3(3): 704 doi: 10.3892/ol.2011.546
|
| 20 |
Daniele Nicolini, Federico Mocchegiani, Gioia Palmonella, Martina Coletta, Marina Brugia, Roberto Montalti, Giammarco Fava, Augusto Taccaliti, Andrea Risaliti, Marco Vivarelli, Gianfranco Alpini. Postoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft’s Function and Predict Survival after Liver Transplantation. PLOS ONE 2015; 10(7): e0133153 doi: 10.1371/journal.pone.0133153
|
| 21 |
Carina Gabriela Correa, Bruno da Silveira Colombo, Marcelo Fernando Ronsoni, Pedro Eduardo Soares e Silva, Leonardo Fayad, Telma Erotides Silva, Letícia Muraro Wildner, Maria Luiza Bazzo, Esther Buzaglo Dantas-Correa, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis. World Journal of Hepatology 2016; 8(17): 739-748 doi: 10.4254/wjh.v8.i17.739
|
| 22 |
Karen Bonefeld, Søren Møller. Insulin-like growth factor-I and the liver. Liver International 2011; 31(7): 911 doi: 10.1111/j.1478-3231.2010.02428.x
|
| 23 |
Eun Ju Cho, Jeong-Hoon Lee, Jeong-Ju Yoo, Won-Mook Choi, Min Jong Lee, Yuri Cho, Dong Hyeon Lee, Yun Bin Lee, Jung Hee Kwon, Su Jong Yu, Jeong Min Lee, Kyung-Suk Suh, Kion Kim, Yoon Jun Kim, Jung-Hwan Yoon, Chung Yong Kim, Hyo-Suk Lee. Serum Insulin-like Growth Factor-I Level Is an Independent Predictor of Recurrence and Survival in Early Hepatocellular Carcinoma: A Prospective Cohort Study. Clinical Cancer Research 2013; 19(15): 4218 doi: 10.1158/1078-0432.CCR-12-3443
|
| 24 |
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review). International Journal of Oncology 2012; 41(6): 1919 doi: 10.3892/ijo.2012.1666
|
| 25 |
Fen-Yu Tseng, Yen-Ting Chen, Yu-Chiao Chi, Pei-Lung Chen, Wei-Shiung Yang. Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves’ disease patients with hyperthyroidism or subjects with euthyroidism. Medicine 2019; 98(11): e14862 doi: 10.1097/MD.0000000000014862
|
| 26 |
Ahmed O. Kaseb, Lianchun Xiao, Manal M. Hassan, Young Kwang Chae, Ju-Seog Lee, Jean-Nicolas Vauthey, Sunil Krishnan, Sheree Cheung, Hesham M. Hassabo, Thomas Aloia, Claudius Conrad, Steven A. Curley, John M. Vierling, Prasun Jalal, Kanwal Raghav, Michael Wallace, Asif Rashid, James L. Abbruzzese, Robert A. Wolff, Jeffrey S. Morris. Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma. JNCI: Journal of the National Cancer Institute 2014; 106(5) doi: 10.1093/jnci/dju088
|
| 27 |
Chisato Saeki, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota. Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1233928
|
| 28 |
Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adamek, Anna Gozdzicka-Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesis. Mutation Research/Reviews in Mutation Research 2017; 772: 78 doi: 10.1016/j.mrrev.2016.08.007
|
| 29 |
R. M. Kurabekova, O. M. Tsirulnikova, S. Yu. Oleshkevich, I. E. Pashkova, G. A. Olefirenko. Impact of the growth hormone and IGF-1 on graft function and immune response in pediatric liver recipients. Russian Journal of Transplantology and Artificial Organs 2022; 24(2): 65 doi: 10.15825/1995-1191-2022-2-65-70
|
| 30 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
|
| 31 |
Mohamed Yousry Elsammak, Gamal M. Amin, Gehan M. Khalil, Wafaa S. Ragab, Mona M. Abaza. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clinical Biochemistry 2006; 39(6): 623 doi: 10.1016/j.clinbiochem.2006.01.022
|
| 32 |
Ghada F. Helaly, Nabila G. Hussein, Wael Refai, Mervat Ibrahim. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance. Translational Research 2011; 158(3): 155 doi: 10.1016/j.trsl.2011.04.005
|
| 33 |
Emelyne Dejeux, Virginie Audard, Catherine Cavard, Ivo Glynne Gut, Benoit Terris, Jörg Tost. Rapid Identification of Promoter Hypermethylation in Hepatocellular Carcinoma by Pyrosequencing of Etiologically Homogeneous Sample Pools. The Journal of Molecular Diagnostics 2007; 9(4): 510 doi: 10.2353/jmoldx.2007.060209
|
| 34 |
Orhan Tarçın, Nursal Gedik, Berna Karakoyun, Veysel Tahan, Gagan Sood, Çiğdem Çelikel, Nurdan Tözün. Serum Prolidase and IGF-1 as Non-invasive Markers of Hepatic Fibrosis During Four Different Periods After Bile-duct Ligation in Rats. Digestive Diseases and Sciences 2008; 53(7): 1938 doi: 10.1007/s10620-007-0073-1
|
| 35 |
Durgul Ozdemir, Ilkay Aksu, Basak Baykara, Mehmet Ates, Ali Riza Sisman, Muge Kiray, Arzu Buyuk, Nazan Uysal. Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats. Toxicology and Industrial Health 2016; 32(1): 39 doi: 10.1177/0748233713498439
|
| 36 |
AGNIESZKA ADAMEK, ALDONA KASPRZAK, HANNA MIKOŒ, WIESŁAWA PRZYBYSZEWSKA, AGNIESZKA SERASZEK-JAROS, ARKADIUSZ CZAJKA, KAROLINA STERZYŃSKA, IWONA MOZER-LISEWSKA. The insulin-like growth factor-1 and expression of its binding protein-3 in chronic hepatitis C and hepatocellular carcinoma. Oncology Reports 2013; 30(3): 1337 doi: 10.3892/or.2013.2546
|
| 37 |
R. Baldelli, A. Bianchi, F. Diacono, M. Passeri, A. Fusco, D. Valle, M. Poggi, M. Terlini, V. Toscano, G. Tamburrano, A. Pontecorvi, G. Maira, L. De Marinis. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas. Journal of Endocrinological Investigation 2005; 28(4): 157 doi: 10.1007/BF03345359
|
| 38 |
Giuliano Bolondi, Federico Mocchegiani, Roberto Montalti, Daniele Nicolini, Marco Vivarelli, Lesley De Pietri. Predictive factors of short term outcome after liver transplantation: A review. World Journal of Gastroenterology 2016; 22(26): 5936-5949 doi: 10.3748/wjg.v22.i26.5936
|